CT European Fund Institutional Accumulation GBPRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 10.5 | 16.8 | -6.2 | 12.8 | 4.8 | |
+/-Cat | 1.1 | 1.4 | 2.6 | -0.8 | 2.3 | |
+/-B’mrk | 2.6 | -0.4 | 1.3 | -2.2 | 0.3 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 4.20 | |
Day Change | -0.51% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB0001439941 | |
Fund Size (Mil) 31/10/2024 | GBP 767.23 | |
Share Class Size (Mil) 21/11/2024 | GBP 319.31 | |
Max Initial Charge | - | |
Ongoing Charge 31/03/2024 | 1.63% |
Investment Objective: CT European Fund Institutional Accumulation GBP |
The Fund aims to achieve capital growth over the long term. It looks to outperform the FTSE World Europe ex UK Index over rolling 3-year periods, after the deduction of charges. The Fund is actively managed, and invests at least 75% of its assets in shares of companies domiciled in Continental Europe, or which have significant Continental European business operations. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Paul Doyle 24/06/2014 | ||
Frederic Jeanmaire 01/12/2019 | ||
Inception Date 30/09/1985 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CT European Fund Institutional Accumulation GBP | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 6.27 |
SAP SE | Technology | 5.03 |
ASML Holding NV | Technology | 4.94 |
Novartis AG Registered Shares | Healthcare | 4.78 |
Nestle SA | Consumer Defensive | 4.77 |
Increase Decrease New since last portfolio | ||
CT European Fund Institutional Accumulation GBP |